ALERT: Zacks Investment Research, Inc. upgrades CYTODYN ORD SHS from NEUTRAL to OUTPERFORM.
BY Investars Analyst Actions - private
— 3:20 PM ET 04/11/2020
On April 11, 2020 Zacks Investment Research, Inc. upgraded CYTODYN ORD SHS from NEUTRAL to OUTPERFORM.